Cumulative detection and clinical outcomes of ampullary tumors in patients with familial adenomatous polyposis undergoing endoscopic surveillance

Abstract Background Patients with familial adenomatous polyposis (FAP) are at an increased risk of ampullary tumors. This study aimed to evaluate their cumulative detection rate and clinical outcomes. Methods We retrospectively identified consecutive patients with FAP who first visited our hospital in 2007–2023 without a known ampullary tumor. The primary outcome was the cumulative detection of ampullary tumors. The secondary outcomes included the therapeutic outcomes of endoscopic papillectomy (EP) and clinical course of ampullary tumors managed by watchful waiting. Results Among 124 patients with FAP, ampullary tumors were found in 33 (pTis-T1a adenocarcinoma, n = 5; adenoma, n = 28). The median lesion size was significantly larger in the adenocarcinoma group than in the adenoma group (25 mm vs. 10 mm; p = 0.001). The cumulative detection of ampullary tumors linearly increased with age, reaching 33% by 50 years, and was significantly higher in patients with Spigelman stage II–IV disease than in those with stage 0–I ( p = 0.003). EP was performed after the initial detection in 19 patients; 14 patients underwent watchful waiting. 2 (14%) of these subsequently required EP due to lesion growth. Thus, 21 patients underwent EP. Adverse events of EP included pancreatitis (14%), delayed bleeding (38%), and intraprocedural bleeding (5%). Local recurrence occurred in 38%. Conclusions Careful ampullary evaluation is required in older patients with FAP and those with an advanced Spigelman stage. EP was a reasonable therapeutic option, although adverse events and local recurrence require attention. Watchful waiting might be considered under appropriate surveillance.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11535485/v1
Primary Topic
Genetic factors in colorectal cancer
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Cumulative detection and clinical outcomes of ampullary tumors in patients with familial adenomatous polyposis undergoing endoscopic surveillance

Shunsuke Yoshii, Yugo Kai, Noriya Uedo, Takashi Kanesaka et al.
Research Square
Genetic factors in colorectal cancer
preprint

Cumulative detection and clinical outcomes of ampullary tumors in patients with familial adenomatous polyposis undergoing endoscopic surveillance

Shunsuke Yoshii, Yugo Kai, Noriya Uedo, Takashi Kanesaka, Hitoshi Yoshiji, Yasuhiro Tani, Minoru Shigekawa, Ryu Ishihara, Ryoji Takada, Sachiko Yamamoto, Satoki Shichijo, Tomoki Michida, Hitoshi Mori, Koji Higashino, Yoshimi Tanaka, Minoru Kato
preprint en

Abstract

Abstract Background Patients with familial adenomatous polyposis (FAP) are at an increased risk of ampullary tumors. This study aimed to evaluate their cumulative detection rate and clinical outcomes. Methods We retrospectively identified consecutive patients with FAP who first visited our hospital in 2007–2023 without a known ampullary tumor. The primary outcome was the cumulative detection of ampullary tumors. The secondary outcomes included the therapeutic outcomes of endoscopic papillectomy (EP) and clinical course of ampullary tumors managed by watchful waiting. Results Among 124 patients with FAP, ampullary tumors were found in 33 (pTis-T1a adenocarcinoma, n = 5; adenoma, n = 28). The median lesion size was significantly larger in the adenocarcinoma group than in the adenoma group (25 mm vs. 10 mm; p = 0.001). The cumulative detection of ampullary tumors linearly increased with age, reaching 33% by 50 years, and was significantly higher in patients with Spigelman stage II–IV disease than in those with stage 0–I ( p = 0.003). EP was performed after the initial detection in 19 patients; 14 patients underwent watchful waiting. 2 (14%) of these subsequently required EP due to lesion growth. Thus, 21 patients underwent EP. Adverse events of EP included pancreatitis (14%), delayed bleeding (38%), and intraprocedural bleeding (5%). Local recurrence occurred in 38%. Conclusions Careful ampullary evaluation is required in older patients with FAP and those with an advanced Spigelman stage. EP was a reasonable therapeutic option, although adverse events and local recurrence require attention. Watchful waiting might be considered under appropriate surveillance.

Research Square
Osaka International Cancer Institute (JP), Nara Medical University (JP)
Good health and well-being
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon